Not Yet RecruitingNot Applicable

Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.

120 participantsStarted 2025-09-18

Plain-language summary

This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient undergoing minimally invasive myomectomy with either a single intramural or Submucosal fibroid =/\>5cm or * Patients undergoing minimally invasive Myomectomy with =/\> 5 fibroids Exclusion Criteria: * Pregnancy, * Age \<18yo, * Patients undergoing concomitant surgery such as endometriosis surgery, * Suspected malignancy

What they're measuring

Estimated blood loss

Timeframe: Intraoperative (during surgery, which is < 24 hours)

Trial details

NCT IDNCT07182045

SponsorThe University of Texas Health Science Center, Houston

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-09-30

Contact for this trial

Randa Jalloul, MD

3137128603 randa.j.jalloul@uth.tmc.edu

View on ClinicalTrials.gov More Myoma trials